These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1675 related items for PubMed ID: 17324392

  • 1. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS.
    Chem Biol Interact; 2007 Mar 20; 166(1-3):352-9. PubMed ID: 17324392
    [Abstract] [Full Text] [Related]

  • 2. Kinetic modeling of beta-chloroprene metabolism: II. The application of physiologically based modeling for cancer dose response analysis.
    Himmelstein MW, Carpenter SC, Evans MV, Hinderliter PM, Kenyon EM.
    Toxicol Sci; 2004 May 20; 79(1):28-37. PubMed ID: 14976335
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
    Knaak JB, Dary CC, Zhang X, Gerlach RW, Tornero-Velez R, Chang DT, Goldsmith R, Blancato JN.
    Rev Environ Contam Toxicol; 2012 May 20; 219():1-114. PubMed ID: 22610175
    [Abstract] [Full Text] [Related]

  • 8. Kinetic modeling of β-chloroprene metabolism: Probabilistic in vitro-in vivo extrapolation of metabolism in the lung, liver and kidneys of mice, rats and humans.
    Yang Y, Himmelstein MW, Clewell HJ.
    Toxicol In Vitro; 2012 Sep 20; 26(6):1047-55. PubMed ID: 22543297
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Probabilistic dose-response modeling: case study using dichloromethane PBPK model results.
    Marino DJ, Starr TB.
    Regul Toxicol Pharmacol; 2007 Dec 20; 49(3):285-300. PubMed ID: 17949874
    [Abstract] [Full Text] [Related]

  • 11. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L, Gocke E, Lavé T, Pfister T.
    Toxicol Lett; 2009 Nov 12; 190(3):317-29. PubMed ID: 19443141
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene.
    Clewell HJ, Campbell JL, Van Landingham C, Franzen A, Yoon M, Dodd DE, Andersen ME, Gentry PR.
    Inhal Toxicol; 2019 Nov 12; 31(13-14):468-483. PubMed ID: 31992090
    [Abstract] [Full Text] [Related]

  • 14. Determination of age and gender differences in biochemical processes affecting the disposition of 2-butoxyethanol and its metabolites in mice and rats to improve PBPK modeling.
    Corley RA, Grant DM, Farris E, Weitz KK, Soelberg JJ, Thrall KD, Poet TS.
    Toxicol Lett; 2005 Mar 28; 156(1):127-61. PubMed ID: 15705493
    [Abstract] [Full Text] [Related]

  • 15. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans.
    Tardif R, Charest-Tardif G, Brodeur J, Krishnan K.
    Toxicol Appl Pharmacol; 1997 May 28; 144(1):120-34. PubMed ID: 9169076
    [Abstract] [Full Text] [Related]

  • 16. Physiologically-based pharmacokinetic and toxicokinetic models in cancer risk assessment.
    Krishnan K, Johanson G.
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005 May 28; 23(1):31-53. PubMed ID: 16291521
    [Abstract] [Full Text] [Related]

  • 17. Steady-state solutions to PBPK models and their applications to risk assessment I: Route-to-route extrapolation of volatile chemicals.
    Chiu WA, White P.
    Risk Anal; 2006 Jun 28; 26(3):769-80. PubMed ID: 16834633
    [Abstract] [Full Text] [Related]

  • 18. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW, Crump KS.
    Crit Rev Toxicol; 2008 Jun 28; 38 Suppl 1():1-47. PubMed ID: 18671157
    [Abstract] [Full Text] [Related]

  • 19. Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone.
    Gentry PR, Covington TR, Clewell HJ, Anderson ME.
    J Toxicol Environ Health A; 2003 Dec 12; 66(23):2209-25. PubMed ID: 14612334
    [Abstract] [Full Text] [Related]

  • 20. Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences.
    Quick DJ, Shuler ML.
    Biotechnol Prog; 1999 Dec 12; 15(3):540-55. PubMed ID: 10356275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 84.